Abstract
In the present study, we designed a novel targeted multi-functional fusion protein LHAD composed of LL-37, FXa recognition peptide, hirudin-12-residue, AAP, and RGD peptide. It was expressed in the Pichia pastoris GS115 strain and purified by affinity chromatography. The in vitro studies suggested that the novel designed protein exhibited antibacterial activity, anti-platelet aggregation and anti-thrombin activities. Moreover, the capability of anti-thrombin was significantly increased compared to that of natural hirudin. Our study may provide a potential approach to design multi-functional drugs for the prevention and management of thrombosis.
Similar content being viewed by others
Abbreviations
- VEC:
-
Vascular endothelial cell
- RGD:
-
Arg-Gly-Asp
- AAP:
-
pGlu-Asn-Trp
- EK:
-
Enterokinase
- FXa:
-
Activated factor X
- Amp:
-
Ampicillin
- ADP:
-
Adenosine diphosphate
- ATU:
-
Antithrombin unit
- kDa:
-
Kilo-dalton
- PT:
-
Prothrombin time
- APTT:
-
Activated partial thromboplastin time
- GpIIb/IIIa:
-
Glycol-protein IIb/IIIa
- PBS:
-
Phosphate buffered saline
- PBST:
-
Phosphate buffered saline Tween-20
- LDAO:
-
Lauryldimethylamine N-oxide
- Ni-IDA:
-
Nickel-iminidoacetic acid
- BSA:
-
Bovine serum albumin
- DAB:
-
Diaminobenzidine
- SPSS:
-
Statistical product and service solutions
- BMM:
-
Buffered methanol medium
- BMMY:
-
Buffered methanol-complex medium
- LB:
-
Luria Bertani medium
- PRP:
-
Platelet rich plasma
- PPP:
-
Platelet-poor plasma
- SOE PCR:
-
Splicing by overlap extension PCR
References
Bals R (2000) Respir Res 1:141–150
Breddin HK (2002) Pathophysiol Haemost Thromb 3:1–8
Davidson DJ, Currie AJ, Reid GSD, Bowdish DME, MacDonald KL, Ma RC, Hancock REW, Speert DP (2004) J Immunol 2:1146–1156
Dugina TN, Kiseleva FV, Chistov IV, Umarova BA, Strukova SM (2002) Biochemistry 1:65–74
Dürr UH, Sudheendra US, Ramamoorthy A (2006) Biochim Biophys Acta 9:1408–1425
Eriksson BI, Wille-Jørgensen P, Kälebo PA, Mouret P, Rosencher N, Bosch P, Baur M, Ekman S, Bach D, Lindbratt S, Close P (1997) N Engl J Med 19:1329–1335
Esmon CT (2000) Blood 4:1113–1116
Esmon CT (2001) Thromb Haemost 1:51–56
Imura Y, Stassen JM, Bunting S, Stockmans F, Collen D (1992) Blood 80:1247–1253
Jakubowski JA, Maraganore JM (1990) Blood 2:399–406
Klement P, Liao P, Hirsh J, Johnston M, Weitz JI (1998) J Lab Clin Med 3:181–185
Koczulla R, Von DG, Kupatt C, Krötz F, Zahler S, Gloe T, Issbrücker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R (2003) J Clin Invest 11:1665–1672
Koh CY, Kini RM (2009) Thromb Haemost 3:437–453
Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC (1995) Infect Immun 4:1291–1297
Levi M, Keller TT, Van GE, Ten CH (2003) Cardiovasc Res 1:26–39
Libby P (2006) Am J Clin Nutr 2:456–460
Markwardt F (1994) Thromb Res 74:1–23
Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, Nagaoka I (2002) Immunology 1:20–26
Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock REW (2002) J Immunol 7:3883–3891
Tjabranga GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sørensen OE, Borregaard N, Rabe KF, Hiemstra PS (2003) J Immunol 12:6690–6696
Tomiyama Y, Tsubakio T, Piotrowicz RS, Kurata Y, Loftus JC, Kunicki TJ (1992) Blood 9:2303–2312
Vyas SP, Vaidya B (2009) Expert Opin Drug Deliv 5:499–508
Xiong J, Fang W, Fang WR, Li B, Huo JL, Kong Y, Li YM (2009) Pharm Pharmacol 1:89–94
Yang De, Chen Q, Albert PS, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O (2000) J Exp Med 7:1069–1074
Zhang JG, Krajden OB, Kainthan RK, Kizhakkedathu JN, Constantinescu I, Brooks DE, Gyongyossy-Issa MIC (2008) Bioconjug Chem 6:1241–1247
Acknowledgments
This work was supported by key scientific and technological project of Chongqing (NO: CSTC, 2009AB5174), and by the Fundamental Research Funds for the Central Universities (NO: CDJZR10230018). We thank Prof. Donald Grierson (Nottingham University) for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gao, J., Hu, Z., Zhao, Z. et al. A Novel Targeted Multi-Functional Fusion Protein Possesses Inhibitory Activities Against Bacteria, Thrombin and Platelet Aggregation. Protein J 30, 521–528 (2011). https://doi.org/10.1007/s10930-011-9357-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-011-9357-6